In vivo characterization of downfield peaks at 9.4 T: T2relaxation times, quantification, pH estimation, and assignments
In vivo characterization of downfield peaks at 9.4 T: T2relaxation times, quantification, pH estimation, and assignments
复制标题
DOI:
10.1002/mrm.28442
复制
发表时间:
2020-08-11
影响因子:
3.3
通讯作者:
Henning, Anke
中科院分区:
文献类型:
--
作者:
Borbath, Tamas;Murali-Manohar, Saipavitra;Henning, Anke
Purpose Relaxation times are a valuable asset when determining spectral assignments. In this study, apparent T(2)relaxation times (T2app) of downfield peaks are reported in the human brain at 9.4 T and are used to guide spectral assignments of some downfield metabolite peaks. Methods Echo time series of downfield metabolite spectra were acquired at 9.4 T using a metabolite-cycled semi-LASER sequence. Metabolite spectral fitting was performed using LCModel V6.3-1L while fitting a pH sweep to estimate the pH of the homocarnosine (hCs) imidazole ring.T2appwere calculated by fitting the resulting relative amplitudes of the peaks to a mono-exponential decay across the TE series. Furthermore, estimated tissue concentrations of molecules were calculated using the relaxation times and internal water as a reference. Results T2appof downfield metabolites are reported within a range from 16 to 32 ms except for homocarnosine withT2appof 50 ms. CorrectingT2appfor exchange rates (T2corr) resulted in relaxation times between 20 and 33 ms. The estimated pH values based on hCs imidazole range from 7.07 to 7.12 between subjects. Furthermore, analyzing the linewidths of the downfield peaks and theirT2appcontribution led to possible peak assignments. Conclusion T2apprelaxation times were longer for the assigned metabolite peaks compared to the unassigned peaks. Tissue pH estimation in vivo with proton MRS and simultaneous quantification of amide protons at 8.30 +/- 0.15 ppm is likely possible. Based on concentration, linewidth, and exchange rates measurements, tentative peak assignments are discussed for adenosine triphosphate (ATP), N-acetylaspartylglutamate (NAAG), and urea.